Related references
Note: Only part of the references are listed.Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin
Rosemary O'Brien et al.
CANCER RESEARCH (2016)
β-Catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition
Er Nie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Dyskerin Overexpression in Human Hepatocellular Carcinoma Is Associated with Advanced Clinical Stage and Poor Patient Prognosis
Bei Liu et al.
PLOS ONE (2012)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
Olga Mendez et al.
MOLECULAR CANCER (2010)
Molecular Therapeutic Targets for Glioma Angiogenesis
Shingo Takano et al.
JOURNAL OF ONCOLOGY (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
The human side of hypoxia-inducible factor
Thomas G. Smith et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Maria Barna et al.
NATURE (2008)
High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
Erik Fredlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia
Delphine Poncet et al.
BLOOD (2008)
Dyskeratosis congenita: a genetic disorder of many faces
M. Kirwan et al.
CLINICAL GENETICS (2008)
DKC1 is a direct and conserved transcriptional target of c-MYC
Faizan Alawi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer
L. Montanaro et al.
JOURNAL OF PATHOLOGY (2006)
Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration
Lei Wang et al.
JOURNAL OF NEUROSCIENCE (2006)
Translational control in stress and apoptosis
M Holcik et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Correlation of N-cadherin expression in high grade gliomas with tissue invasion
K Asano et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification
D Ruggero et al.
SCIENCE (2003)
Brain and other central nervous system cancers: Recent trends in incidence and mortality - Response
JM Legler et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
